What’s the Buzz

(FDA) issued an emergency use authorization (EUA) for bebtelovimab, a new monoclonal antibody treatment for COVID-19.

Last week, the first 10 prescription drugs subject to Medicare price negotiations were announced. Learn more about how it might affect the healthcare industry in the future.

Jack joined BuzzRx in July 2021 and, because of his success and dedication as a BuzzRx Representative, has been named our Q2 2023 MVP!

BuzzRx is proud to celebrate 4 million meals donated through our 16 Food Bank partnerships.

This month marks the ninth year of the popular Red Nose Day, an annual fundraising campaign to end child poverty. It’s crucial that everyone do their part to to give back to their communities.

Priscilla joined BuzzRx in June 2021 and, because of her success and dedication as a BuzzRx Representative, has been named our Q1 2023 MVP!

Michelle joined BuzzRx in May 2019 and, because of her success and dedication as a BuzzRx Representative, has been named our Q4 2022 MVP!

Amazon is ending its nearly 10-year-old philanthropy program, AmazonSmile. Read more about Amazon’s decision and what lessons can be learned from a strategic corporate giving perspective.

This October marks one year since Lauren joined BuzzRx, and because of her success and dedication as a BuzzRx Representative, has been named our Q3 MVP!

This upcoming November marks eight years since BuzzRx launched our national partnership with Make-A-Wish®.

The Inflation Reduction Act of 2022 includes several provisions to reduce drug spending by the federal government. Our CEO examines the potential impact on prescriptions for Medicare beneficiaries.

Experts warn that antimicrobial resistance--the ability of microorganisms to grow despite the presence of drugs designed to kill them--could be the next pandemic.